ASSESSMENT OF GENITAL AND URINARY TRACT INFECTIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH DAPAGLIFLOZIN
Last updated: 25 Dec 2024
10.21608/bfsa.2022.271776
Type 2 diabetes mellitus, Dapagliflozin, Urinary Tract infections, Genital infections, risk factors
Hiba
Mayhoub
Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tishreen University, Lattakia, Syria
hibamay693@yahoo.com
Arige
BouBou
Department of Internal Medicine (Endocrinology), Faculty of Medicine, Tishreen University, Lattakia, Syria
arigeboubou@yahoo.fr
Nisrin
Kaddar
Department of Pharmaceutics and Pharmaceutical Technology، Faculty of Pharmacy, Tishreen University, Lattakia, Syria
nkaddar@yahoo.fr
45
2
37882
2022-12-01
2022-04-07
2022-12-01
953
965
1110-0052
3009-7703
https://bpsa.journals.ekb.eg/article_271776.html
https://bpsa.journals.ekb.eg/service?article_code=271776
271,776
Original Article
1,096
Journal
Bulletin of Pharmaceutical Sciences Assiut University
https://bpsa.journals.ekb.eg/
ASSESSMENT OF GENITAL AND URINARY TRACT INFECTIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TREATED WITH DAPAGLIFLOZIN
Details
Type
Article
Created At
22 Jan 2023